doxapram has been researched along with Hypoventilation in 7 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Hypoventilation: A reduction in the amount of air entering the pulmonary alveoli.
Excerpt | Relevance | Reference |
---|---|---|
"Doxapram is a respiratory stimulating drug that affects both peripheral chemoreceptors and medullary respiratory and nonrespiratory neurons." | 5.26 | Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. ( Hunt, CE; Inwood, RJ; Shannon, DC, 1979) |
"Doxapram is a respiratory stimulating drug that affects both peripheral chemoreceptors and medullary respiratory and nonrespiratory neurons." | 1.26 | Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. ( Hunt, CE; Inwood, RJ; Shannon, DC, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Richards, JR | 1 |
Laurin, EG | 1 |
Bretz, SW | 1 |
Traylor, BR | 1 |
Panacek, EA | 1 |
Owen-Falkenberg, AP | 1 |
Marsac, J | 1 |
Bouchoucha, S | 1 |
Ruff, F | 1 |
Hunt, CE | 1 |
Inwood, RJ | 1 |
Shannon, DC | 1 |
Houser, WC | 1 |
Schlueter, DP | 1 |
Haddad, GG | 1 |
Mazza, NM | 1 |
Defendini, R | 1 |
Blanc, WA | 1 |
Driscoll, JM | 1 |
Epstein, MA | 1 |
Epstein, RA | 1 |
Mellins, RB | 1 |
Jansen, JE | 1 |
Sorensen, AI | 1 |
Naesh, O | 1 |
Erichsen, CJ | 1 |
Pedersen, A | 1 |
1 review available for doxapram and Hypoventilation
Article | Year |
---|---|
[The treatment of chronic alveolar hypoventilation (not including physiotherapy and artificial ventilation) (author's transl)].
Topics: Almitrine; Bronchodilator Agents; Carbonic Anhydrase Inhibitors; Central Nervous System; Central Ner | 1979 |
1 trial available for doxapram and Hypoventilation
Article | Year |
---|---|
Effect of doxapram on postoperative pulmonary complications after upper abdominal surgery in high-risk patients.
Topics: Abdomen; Adult; Aged; Blood Gas Analysis; Cough; Double-Blind Method; Doxapram; Drug Administration | 1990 |
5 other studies available for doxapram and Hypoventilation
Article | Year |
---|---|
Treatment of ethanol poisoning and associated hypoventilation with doxapram.
Topics: Central Nervous System Stimulants; Doxapram; Emergency Service, Hospital; Ethanol; Humans; Hypoventi | 2016 |
[Doxapram hydrochloride. Treatment of postoperative hypoventilation caused by fentanyl].
Topics: Doxapram; Female; Fentanyl; Humans; Hypoventilation; Middle Aged; Postoperative Complications | 1980 |
Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome.
Topics: Chemical and Drug Induced Liver Injury; Doxapram; Duodenal Ulcer; Dyskinesia, Drug-Induced; Humans; | 1979 |
Prolonged doxapram infusion in obesity-hypoventilation syndrome.
Topics: Acute Disease; Adult; Doxapram; Female; Humans; Hypoventilation; Infusions, Parenteral; Obesity; Res | 1978 |
Congenital failure of automatic control of ventilation, gastrointestinal motility and heart rate.
Topics: Doxapram; Female; Heart Rate; Humans; Hypoventilation; Infant, Newborn; Megacolon; Respiration; Resp | 1978 |